1. Target therapy in NSCLC patients: Relevant clinical agents and tumour molecular characterisation
   PAOLA ULIVI et al, 2013, Molecular and Clinical Oncology CrossRef
2. Peripheral Blood for Epidermal Growth Factor Receptor Mutation Detection in Non-Small Cell Lung Cancer Patients
   Xuefei Li et al, 2014, Translational Oncology CrossRef
3. Role of circulating-tumor DNA analysis in non-small cell lung cancer
   Tao Jiang et al, 2015, Lung Cancer CrossRef
4. Investigation on the efficiency of Brucea javanica oil emulsion injection with chemotherapy for treating malignant pleural effusion: A meta-analysis of randomized controlled trials
   Rui Shi et al, 2022, Frontiers in Pharmacology CrossRef
5. Update of epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer
   Yuh-Min Chen, 2013, Journal of the Chinese Medical Association CrossRef
6. Can EGFR mutations in plasma or serum be predictive markers of non-small-cell lung cancer? A meta-analysis
   Ying Wu et al, 2015, Lung Cancer CrossRef
7. Liquid biopsy and NSCLC
   Domenico Trombetta et al, 2016, Lung Cancer Management CrossRef
8. Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer
   Paola Ulivi et al, 2013, Cellular Oncology CrossRef
9. Blood as a Substitute for Tumor Tissue in Detecting EGFR Mutations for Guiding EGFR TKIs Treatment of Nonsmall Cell Lung Cancer
   Chen Mao et al, 2015, Medicine CrossRef